The multicellular tumor spheroid (MCTS) model represents a suitable in vitro model recreating in vivo tumor formation. The aim of this study was to identify differentially expressed genes that could potentially serve as predictive gene markers for MCTS and be involved in the formation of MCTS. Using the suppression subtractive hybridization (SSH) method, we identified ERBB2/HER2-interacting protein (Erbin), Tumor rejection gp96 (Tr-gp96), 12S ribosomal RNA (12S rRNA), ATP synthase, Kruppel-like transcription factor 5 (KLF5), transcription factor-like 5 (TCFL5), and the dual-specificity phosphatase 11 (DUSP11) to be overexpressed in 3-dayold HT-29 colon carcinoma MCTSs compared to HT-29 colon carcinoma cells grown in monolayer. We could also confirm overexpression of these genes in HT-29 MCTSs and in MCTSs formed by the human glioblastoma tumor cell lines U343 MG, U373 MG, and DBTRG 05 MG. Knockdown of KLF5, Erbin, DUSP11, and TCFL5 was effectively achieved after transfection of HT-29 cells with the appropriate short-interfering RNAs (siRNAs), and correlated with a significant inhibition of MCTS formation in the case of KLF5, Erbin, and TCFL5 siRNAs. We suggest that KLF5, Erbin, and TCFL5 are essential for MCTS formation and play a key role in the development of tumor diseases.
INTRODUCTION
The pathology of human cancer involves several biological characteristics such as abnormal cell proliferation and adhesion, the ability to evade apoptosis, abnormal angiogenesis, and the ability to invade tissues and metastasize. 1 After complete sequencing of the human genome and significant advances in genomics and proteomics, discovering target genes for therapeutic intervention of severe human diseases, such as cancer, remains as a future challenge. In this context, identification of genes relevant for cancer development requires an appropriate culture model reflecting the in vivo situation. More recently, it has been recognized that compared to two-dimensional systems, the three-dimensional cell culture systems better reflect the in vivo behavior of most cell types. There is evidence that the model of two-dimensional growth of tumor cells in monolayers is inappropriate for studying all aspects of tumor formation (for review, see refs. [2] [3] [4] [5] . The shortcoming of the two-dimensional culture system is attributed to the fact that such systems do not mimic the response of cells in the three-dimensional microenvironment present in a tissue or tumor in vivo (for review see refs. 2, 5) . In contrast to non-malignant cells, tumor cells are able to form multicellular tumor spheroids (MCTSs) in an anchorage-independent manner. The ability of tumor cells to grow in an anchorage-independent manner is considered to be a classic indicator of in vivo tumorigenesis. 3, [5] [6] [7] In this context, most of the transformed tumor cells are able to grow in an anchorage-independent manner and to form MCTSs. On the other hand, some of the tumorigenic cell lines are able to grow in an anchorage-independent manner (on adhesive plates) without forming spheroids. 8, 9 These findings suggest that the anchorageindependent growth is a separate characteristic of cancer cells from their growth as spheroids.
Three-dimensional MCTSs are formed after dissociation of two-dimensional monolayer cancer cells by various in vitro methods. As a result of their three-dimensional multicellular structure, MCTSs strongly resemble solid tumors. As in a solid tumor, cells in the MCTSs are exposed to non-uniform oxygen and nutrient levels as well as additional stress signals (for reviews, see refs. 2, 5) .
Remarkably, it was repeatedly demonstrated that MCTSs are much more resistant to DNA-damaging ionizing radiation and chemotherapeutic drug treatment in comparison to monolayer cell cultures. 3, 5, 7 Therefore, the MCTS model offers a potential model suitable for identification of target genes that are functionally involved in MCTS formation as well as in their resistance to radiation and drugs. Such genes might be of fundamental importance for therapeutic intervention.
In this study, we used HT-29 cells as a cellular model for an early developmental stage of colon carcinoma. To identify common target genes that may be involved in the process of MCTS formation by various tumor cells, we recently identified 40 transcripts that are induced at least two-fold in 3-day-old MCTSs relative to normal adherent cells. 10 To discover additional relevant genes for formation of MCTSs, we applied the suppression subtractive hybridization (SSH) method 11, 12 by comparing control adherent HT-29 tumor cells (driver) and 3-day-old HT-29 MCTSs (tester). Moreover, expression of the identified genes in HT-29 MCTSs was also studied in MCTSs formed by the human glioblastoma tumor cell lines U343 MG, U373 MG, and DBTRG 05 MG. After transfection of HT-29 cells with specific short-interfering RNAs (siRNAs) we identified three candidate genes that are involved in the spheroid formation of HT-29 cells.
RESULTS

Identification of differentially expressed genes in HT-29 MCTSs by the SSH method
To identify potential target genes that are involved in the formation of MCTSs by HT-29 colon carcinoma cells, mRNA from 3-day-old HT-29 MCTSs (tester) and single HT-29 cells (driver) was isolated ( Figure 1) . After reverse transcription into cDNA and digestion with RsaI, two different adapters were separately ligated to the digested tester cDNA for the SSH procedure. After the first hybridization of the two different tester cDNAs with an excess of denatured driver-cDNA in separate samples and a second hybridization step, the subsequent PCR amplification was performed without denaturation. Following polyacrylamide electrophoresis, subtracted cDNA fragments of different sizes were detected (Figure 2a Figure 2b , discrete cDNA fragments could be resolved by this procedure. The reamplified cDNA fragments were inserted into the cloning vector and sequenced using M13 primers. After nucleic acid homology (homology greater than 97%) searches, 12 different human cDNAs that represent overexpressed transcripts in the 3-day-old HT-29 MCTSs were identified (see Table 1 ).
Identification of differentially expressed genes in tumor MCTSs by reverse transcriptase-polymerase chain reaction (RT-PCR) and by quantitative real-time PCR To confirm expression of genes in HT-29 MCTSs identified by the SSH method, we applied the RT-PCR method using genespecific primers (see Supplementary Table S1 ). In this context, cDNA fragments containing additional upstream and/or downstream sequences of the matched cDNA sequences were amplified (see Table 1 ). As indicated in Figure 3a , Erbin, Tr-gp96, 12S rRNA, ATP-Synthase, KLF5, TCFL5, and DUSP11 are overexpressed in 3-day-old HT-29 MCTSs. However, overexpression of EF-1a, RP-L13a, RP-L39 Cytokeratin 18, and Heat shock protein 70 kd (HSP70) in HT-29 MCTSs could not be demonstrated by RT-PCR. Expression of Erbin, Tr-gp96, TCFL5, DUSP11, and KLF5 could also be observed in the U373 MCTSs ( Figure 3b) . However, no difference in the expression level of ATP synthase and 12S rRNA mRNA could be detected in single cells and U373 MCTSs. Compared to HT-29 ( Figure 3a ) and U373 MCTSs (Figure 3b ), U343 cells were less tightly packed in the MCTSs (Figure 3c) . In contrast to HT-29 and U373 MCTSs, relatively small U343 MCTSs were attached on the bacteriological dishes whereas the larger ones were floating in the medium. Similarly, all identified genes, apart from DUSP11, were overexpressed in U343 MCTSs (Figure 3c) . However, expression of KLF5 could not be detected even after 35 PCR cycles. Similar to the U343 MCTSs, DBTRG 05 cells were less tightly packed in the MCTSs. All genes overexpressed in HT-29 MCTSs were also overexpressed in the DBTRG05 MCTSs (Figure 3d) .
Expression of KLF5 and Tr-gp96 in HT-29 cells was selected to be additionally tested with qRT-PCR. As shown in Figure 3a Inhibition of the KLF5, TCFL5, and Erbin mRNA expression in HT-29 cells results in an inhibition of MCTS growth/formation To determine the role of some of the genes that were upregulated in HT-29 MCTSs, knockdown of these genes was performed by transfection of HT-29 cells with specific siRNAs against DUSP11, KLF5, Erbin, and TCFL5. As demonstrated in Figure 4a (representative gels) and Figure 4b (evaluation of three independent experiments by densitometric analysis of intensity of the bands), treatment of the cells for 48 h resulted in a 60, 50, Supplementary Table S1 . The sizes of the resulting PCR products are shown on the right. As an internal control, PCR reactions were performed for each gene in the presence of the b-tubulin primers.
53, and 51% inhibition of the mRNA expression, respectively. Compared to the mRNA expression level of the untreated cells, the transfection vehicle did not influence the mRNA expression level ( Figure 4a ). As the MCTS formation is dependent both on proliferation and adhesion processes, we first analyzed whether treatment of HT-29 cells influenced the proliferation rate of the cells cultured on cell culture dishes in the monolayer form. For this, cultured cells on monolayers were first treated with the appropriate dsRNA for 48 h, then cells were trypsinized, cultured for 3 days and after trypsinization the cell number was determined. As indicated in Figure 5a , suppression of KLF5, Erbin, and TCFL5 mRNA expression resulted in a statistically significant 25, 15, and 14% inhibition of proliferation, respectively. Suppression of the DUSP11 mRNA did not influence the proliferation rate of the HT-29 cells. Again, the transfection vehicle did not influence the proliferation rate of the cells. Next, we examined whether suppression of the mRNA levels correlates with the ability of the HT-29 cells to form MCTSs. For this purpose, cultured cells in the monolayer form were treated with the appropriate dsRNAs for 48 h and then cells were cultured in bacteriological dishes for 3 days. For quantification of the inhibitory effects of the dsRNAs on MCTS formation, the appropriate dishes were scanned and the number and size of the MCTSs were determined using ImageJ software ( Figure 5b , right panel). In this representative experiment, we found 522 MCTSs with a Feret's diameter of 2967133 mm in vehicle-treated cells, whereas only 88 MCTSs were found with a Feret's diameter of 267782 mm in cells treated with KLF5 dsRNA. Feret's diameter is defined as the longest distance between any two points along the boundary of the particles (in this case, MCTSs) (for more information, see http:// rsb.info.nih.gov/ij/docs/). Evaluation of three independent experiments is shown in Figure 5c . Notably, reduction of the KLF5, Erbin, and TCFL5 mRNA expression resulted in 90, 78, and 64% inhibition of the number of the MCTSs, respectively.
The effect of dsRNAs directed to KLF5 and TCFL5 mRNA on gene expression in HT-29 cells was confirmed by qRT-PCR ( Figure 6 ). In both cases, both controls show corresponding DC t values, whereas the effect of dsRNA is seen via a decrease in expression of the associated gene. In the case of KLF5, the decrease is more than half (mean DC t controls ¼ 2.52, mean DC t dsRNA ¼ 3.58): in the case of TCFL5, the decrease is almost fourfold (mean DC t controls ¼ 3.27, mean DC t dsRNA ¼ 5.04). As a negative control we used a specific dsRNA against lamin. As shown, lamin dsRNA had no effects on KLF5 and TCFL5 mRNA expression.
MCTS formation of HT-29 cells correlates with an increase of Erbin protein and inhibition of the Erbin mRNA expression in HT-29 cells results in an inhibition of the Erbin protein
To confirm that inhibition of the Erbin mRNA results in an inhibition of the Erbin protein, a parallel isolation of the total mRNA and protein was performed from the same cells. As demonstrated in Figure 7a , inhibition of the Erbin mRNA also reflects inhibition of the Erbin protein by 50%. As a negative control, we used a specific siRNAs against laminin. As shown, laminin dsRNA had no effects on the Erbin mRNA and protein expression. As demonstrated in Figure 7b , an elevation of the Erbin mRNA in HT-29 MCTSs correlates well with an increase of the Erbin protein.
DISCUSSION
Anchorage-independent multicellular aggregates have been used in developmental biology and cancer research. 3, 5, 7 In this context, it is well known that embryonic stem cells are able to form multicellular aggregates and induce tumorigenicity in vivo after transplantation (for review, see ref. 13 ). However, nontransformed chondrocytes and hepatocytes are also capable of anchorage-independent growth in soft agar. 14, 15 It is established that the anchorage-independent MCTS model serves as an indicative model for the malignant transformation of cells and correlates with their tumorigenicity. As the MCTS model resembles more closely the threedimensional environment, it may represent a better model system to identify cancer-associated genes.
3,5-7 Furthermore, identification of target genes that are involved in the formation of MCTSs is essential for understanding molecular and cellular with the appropriate dsRNAs (each 100 nM) was performed for 48 h. Upon isolation of total RNA, RT-PCR was performed using the respective primers shown in Supplementary Table S1 for DUSP11 and Erbin and the primers for the KLF5 and TCFL5 mRNA as indicated in the siRNA and transfection chapter (see Materials and methods). As an internal loading control, PCR reactions were performed using the b-tubulin primers (Supplementary Table S1 ). (b) Densitometric analysis of three independent experiments (mean7SD, n ¼ 3, *Po0.05 for the dsRNAitreated versus vehicle-treated cells).
aspects of cancer development in vivo and may be candidates for therapeutic intervention for several forms of cancer. Moreover, the MCTS model is of clinical relevance as application of this model may significantly accelerate the discovery of new drugs for anticancer therapy (for review, see refs. 2,3,5,7).
Based on our SSH gene expression analysis of HT-29 single cell suspensions and cells that underwent spheroid formation, we identify a set of candidate genes that may be involved in tumor development. From the 12 different human cDNAs that represent overexpressed transcripts in the 3-day-old HT-29 MCTSs (Table 1) , overexpression of seven transcripts (see Supplementary Table S1 ) has been confirmed by the semiquantitative RT-PCR method. These results demonstrated that 60% of the initially isolated cDNA fragments by SHH were false positive at the confirmation stage. This is the first study demonstrating an upregulation of the genes Erbin, ATP synthase, Tr-gp96, 12S rRNA, TCFL5, KLF5, and DUSP11 in MCTSs compared to single HT-29 cells. Moreover, this is the first study demonstrating that functional gene knockdown of KLF5, Erbin, and TCFL5 by siRNAs resulted in a significant suppression of the number of MCTSs, suggesting a key role of these genes in the development of tumor diseases.
Kruppel-like transcription factor 5 (KLF5) is a regulator of cell growth and tumorigenesis. 16, 17 Expression of KLF5 is detected in proliferating intestinal epithelium, suggesting its growth-promoting role. In this context, it has been shown that Tumor Spheroids and Gene Expression expression of KLF5 in non-transformed intestinal epithelial cells enhances colony formation, cyclin D1 transcription, and cell growth. 16 However, reduced levels of KLF5 mRNA were detected in human familial adenomatous polyposis adenomas compared with normal crypt epithelium suggesting that downregulation of KLF5 is an early event in intestinal tumors. 16 Moreover, overexpression of KLF5 in NIH3T3 cells resulted in an anchorage-independent growth of the cells producing MCTSs. 17 In accordance with these findings, we also observed overexpression of KLF5 in MCTSs formed by various human tumor cells. Moreover, we could clearly demonstrate that inhibition of KLF5 expression in HT-29 cells resulted in an inhibition of MCTS formation. From our findings, we conclude that KLF5 plays an important role in MCTS formation and thus in the development of cancer diseases.
Tyrosine phosphatases play an important role in cellular signalling and networking that is antagonistic to the kinases. Ninety-six homologs of the classical and dual-specific tyrosine phosphatases (DUSPs) were identified in the human genome using sensitive sequence search techniques. 18 DUSPs are inhibitors of the mitogen-activated protein kinase (MAPK) signaling pathway. 19 This is the first report showing a high expression of the DUSP11 in MCTSs formed by human tumor cells. However, suppression of the DUSP11 expression had no effects on MCTS formation. As the members of the DUSP11 family inhibit the MAPK signalling pathway that is involved in the development of cancer diseases, 20 the increased expression of DUSP11 in MCTSs may modulate the increased potential of the cells to form MCTSs.
ERBB receptors have a crucial role in morphogenesis and oncogenesis. 21, 22 Recently, a new PDZ protein called ERBB2-interacting protein (ERBIN or ERBB2-interacting protein) has been identified that acts as an adaptor for the receptor ERBB2/ HER2 in epithelial cells. Furthermore, direct and specific interactions of the PDZ domain of Erbin with ERBB2/HER2 have been demonstrated. The authors suggest that ERBIN acts in the localization and signalling of ERBB2/HER2 in epithelia 23 and plays a key role in epithelial cell polarity. 24 Recent evidence suggests that ERBIN inhibits EGF signaling by preventing the activation of the Raf-1 kinase by Ras 25 and it is a negative regulator of the Ras-Raf-Erk signalling pathway. 26 Interestingly, Supplementary Table S1 for Erbin and anti-Erbin polyclonal antibodies recognizing the 80 kDa Erbin protein, respectively. As an internal loading control, PCR reactions were performed using the b-tubulin primers (Supplementary Table S1 ). overexpression of Erbin leads to inhibition of nerve growth factor-induced neuronal differentiation of PC12 cells, whereas downregulation of endogenous Erbin by specific siRNA exhibits an opposite effect. 26 Moreover, using the SSH method, Erbin has been identified to be highly expressed in MCF7 cells ectopically expressing BRCA1 (tester) compared to control MCF7 breast carcinoma cells (driver). 27 Furthermore, association of Erbin with the junctional cadherin-catenin complex has been demonstrated to be mediated by d-catenin and ARVCF. 28 In this study, we showed that ERBIN is involved in the formation of MCTSs by HT-29 cells. However, further investigations are required for elucidating the role of Erbin in human cancer diseases in detail.
So far, little is known about the function of transcription factor-like 5 (TCFL5). It has been reported that this novel human gene is expressed specifically in primary spermatocytes in the testis, and the cDNA encodes for a 452-amino-acid protein that includes a basic helix-loop-helix (bHLH) motif. Furthermore, the gene product is exclusively located in the cell nuclei of primary spermatocytes at the pachytene stage, but not in those at the leptonema stage. The authors suggest that TCFL5 protein might play a crucial role in spermatogenesis as a transcription factor by regulating cell proliferation or differentiation of cells. 29 More recently, it has been shown that TCFL5 is overexpressed in the spermatocytic seminomas, which are solid tumors found solely in the testis of predominantly elderly individuals. 30 Interestingly, we found a high expression level also in various cell lines forming MCTSs. Furthermore, reduction of the TCFL5 expression in HT-29 cells resulted in a suppression of the MCTSs. These results suggest a functional role of TCFL5 in the development of cancer diseases.
The process of MCTS formation is complex and little is known about the gene sets that are involved in this process. It is conceivable that both adhesion and the proliferation process are essential to form large MCTSs. In this study, we show that KLF5, Erbin, and TCFL5 significantly suppress the number of the MCTSs. As the suppression of cell proliferation by dsRNAs directed towards KLF5, ERBIN, and TCFL5 (25, 15, and 14%) was much more pronounced compared to their effect on the number of MCTSs (90, 78, and 64%, respectively), we may suggest that suppression of the MCTS formation occurs mainly via modulation of the adhesion process. However, it is also possible that the inhibitory effects of dsRNAs on the proliferation of adherent cells is more pronounced compared to the effects in monolayer cells, suggesting that suppression of the MCTS formation occurs via modulation of the proliferation and adhesion process.
In the last decade, it has been suggested that heat shock proteins (HSPs) such as Hsp60, Hsp70, Hsp90, and gp96 may be potent activators of the innate immune system thereby playing an important role in antigen presentation and tumor immunity. 31 The HSPs are located in the endoplasmic reticulum. 31 Interestingly, we found that gp96 is highly expressed in HT-29 MCTSs compared to HT-29 single cells. Recent studies have indicated that gp96 molecules participate in the major histocompatibility complex class I-restricted antigen presentation pathway and vaccination of mice with HSP gp96 resulted in an immune response sufficient for tumor rejection and suppression of metastatic tumors. [31] [32] [33] The ATP synthase (subunit 6) and the 12S rRNA transcripts are encoded by the mitochondrial genome. In general, cancer cells utilize the glycolytic pathway as an energy source more than the aerobic pathway. Neoplastic transformation is accompanied by a decreased amount of mitochondria and, paradoxically, by a marked expression of nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) encoding the enzymes of oxidative phosphorylation (OXPHOS). 34, 35 In this context, a high expression level of mtDNA coding for the 12S rRNA, and ATP synthase 6 was observed in human SV-40-transformed diploid fibroblasts in comparison to the untransformed control cells. 35 Interestingly, we also observed expression of both ATP synthase 6 and 12S rRNA in several human tumor MCTSs.
Recently, there is evidence that some of the differentially expressed genes found by our in vitro model are also differentially expressed in malignant tumor tissues compared to the normal or benign tumor tissues. In this regard, expression of tumor rejection protein gp96 and ATP synthase was also significantly upregulated in malignant primary colorectal cancer compared to the adjacent normal mucosa. 36 In addition, TCFL5 has been found to be overexpressed in early-stage cervical cancers compared to normal cervical epithelium. 37 More recently, immunohistochemistry experiments demonstrated that cytoplasmatic KLF5 was significantly increased in malignant prostate tissues compared to the benign prostate tissues. 38 Notably, these findings support a possible clinical relevance of the overexpressed genes found by the in vitro MCTS model. Furthermore, these genes may represent potential tumor markers for distinct solid tumors and might be considered as possible targets for future anticancer therapies.
It is also possible that these genes may contribute to the resistance of MCTSs to the DNA-damaging radiation and to antitumor drugs. Finally, the role of the remaining genes differentially expressed during MCTS formation remains to be elucidated.
MATERIALS AND METHODS
Materials. All culturing media were obtained from Gibco BRL, (Eggenstein, Germany). Plastic tissue culture dishes were obtained from Falcon (BD Biosciences, Heidelberg, Germany) and bacteriological culture dishes were obtained from Greiner (Kremsmünster, Austria). A rabbit anti-ERBIN polyclonal antibody was kindly provided by JeanPaul Borg (INSERM, Molecular Oncology, Marseille, France) and produced by injecting a soluble GST-ERBIN (914-1, 371) fusion protein as described previously. 39 Cell culture. Human HT-29 colon carcinoma cells and DBTRG-05 MG cells were provided by the Cell Lines Service (Heidelberg, Germany) and by the DSMZ (Braunschweig, Germany), respectively. HT-29 cells were cultured in McCoy's 5A medium supplemented with 10% fetal bovine serum (FBS) (vol/vol), 2 mM glutamine. U373 MG and U343 MG 31L cells were kindly provided by Monica Nister, University of Uppsala, Sweden. DBTRG 05 MG, U373 MG, and U343 MG cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 2 mM glutamine, and 1% NEAA (vol/vol).
Bacteriological Petri dish spheroid assay. After trypsinization of the cultured tumor cells, 5 Â 10 4 single cells were cultured for 3 days in DMEM supplemented with 10% FBS and 1% NEAA (vol/vol) in Petri dishes (Greiner, 664102, 10 cm). After 30 min and after 3 days, cells were photographed by phase-contrast light microscopy.
SSH. Isolation of poly(A)
þ RNA and cDNA synthesis: The SSH was performed between single-cell suspensions obtained through trypsinization of confluent HT-29 cells (driver) and 3-day-old HT-29 MCTSs (tester) as described previously 40 ( Figure 1 ). For preparation of polyadenylated RNA, total RNA was extracted with the TRIzol reagent (Sigma Chemical, Deisenhofen, Germany) and mRNA was purified with the mMACS mRNA isolation kit from Miltenyi Biotec (Bergisch Gladbach, Germany). Further steps were performed according to the producer's instructions using the PCR-Select cDNA subtraction kit (Clontech, Palo Alto, CA, USA). After generation of the cDNA, it was blunted by T4 DNA polymerase for 30 min at 161C. To obtain shorter blunt-ended molecules the cDNA was digested with 15 U RsaI at 371C for 1.5 h. Adapter ligation was performed only with the reversetranscribed and digested mRNA of the tester cDNA. One-half of the tester cDNA was ligated with 2 mM adapter-1, and the other half with 2 mM adapter-2 in the ligation mixture (50 mM Tris-HCl, pH 7.8, 10 mM MgCl 2 , 1 mM DTT, 1 mM ATP, 5% polyethylene glycol, and 0.5 U T4 DNA ligase) at 161C overnight. For the first hybridization, an excess of driver cDNA was added to each tester cDNA (ligated with adapter-1 or -2) in separate samples. After denaturation at 981C for 1.5 min, the first hybridization was performed in a hybridization buffer at 681C for 8 h. For the second hybridization the two samples of the first hybridization were combined without denaturation at 681C overnight.
PCR amplification: A primary PCR was used to selectively amplify the differentially expressed sequences and performed with 1 ml of the diluted subtracted cDNA in a 25 ml volume containing 400 nM of each primer, 0.2 mM dNTPs, and 0.5 ml of Advantage KlenTaq polymerase mix (Clontech) as described previously. 40 Then, 1 ml of the amplified product was used as a template in a secondary PCR. 40 Seven microlitre of the amplified cDNA was separated in a CleanGel Long-10, long-run gel (ETC electrophoresis technique, Kirchentellinsfurt, Germany) by horizontal polyacrylamide electrophoresis (Multiphor II) (Pharmacia Biotech). The gel was subsequently cut in the second lane and the first part was silver stained as described (ETC electrophoresis technique). Distinctly visible bands were excised from the unstained part of the gel and used as a template for an additional round of PCR. The products of the reamplified cDNA fragments were then inserted into the pCR2.1 cloning vector (TOPO-TA cloning kit, Invitrogen, Carlsbad, CA) and transformed in Top F10' cells (Invitrogen). The bacteria were plated on ampicillin-containing agar plates, which were overlaid with 1.4 mg b-XGal and 100 mM IPTG. After overnight incubation, white colonies were picked and transferred into wells of a multiter plate containing 200 ml LB medium and subsequently incubated for 4 h at room temperature. Heating to 1001C for 10 min lysed the bacteria, and 5 ml of each sample was used to amplify the cloned inserts in 50 ml reactions using standard PCR conditions and M13 sequencing primers. DNA sequencing was performed by automated means at the Center of Molecular Medicine (Cologne, Germany).
RT-PCR of detected sequences. To confirm the induction and differential expression of the detected sequences, RT-PCR analyses were performed as described previously. 40 Primers were designed for each of the detected sequences (Supplementary Table S1 ) and synthesized by MWG-Biotech (Ebersberg, Germany).
siRNA and transfection. The siRNA sequence targeting human DUSP11 (CTCGTTTCATTGCTTTCAA-dAdG) was designed as described previously 41 (http://www.rockefeller.edu/labheads/tuschl/sirna. html), and corresponds to the coding region (position from start codon: 139). The optimized siRNAs sequences targeted to the human KLF5, Erbin, and TCFL5 were ordered from Dharmacon (Colorado). These optimized siRNAs have been synthesized in accordance with eight criteria that significantly improve potent siRNA as described previously. 42 Briefly, HT-29 cells cultured in tissue culture dishes (approximately 30% confluence) were transfected using siRNA/Lipofectamine2000 (from MWG/Invitrogen, for DUSP11) or siRNA-SMARTpool/Dharmafect4 (a potent pool of four different gene-specific siRNAs from Dharmacon, for KLF5, ERBIN, and TCFL5) containing 125, 200, and 300 nM DUSP11 or 100 nM KLF5, Erbin, and TCFL5 duplex siRNAs. Control experiments were performed using the vehicle alone (Lipofectamine2000 or Dharmafect4). After 48 h incubation at 371C, cells were harvested for RT-PCR, proliferation assay and the MCTS assay. The RT-PCR reaction was performed using the respective primers and conditions as shown in Supplementary Table S1 for DUSP11 and Erbin. For KLF5 mRNA detection we used the following upper primer, lower primer, and PCR conditions: upper primer, CCCTTGCACATACA CAATGC; lower, AGTTAACTGGCAGGGTGGTG, 561C, 27 cycles (PCR fragment: 206 bp). For detection of TCFL5 mRNA we used the ollowing: upper primer, CTGCCAAGCACCAGGATATT; lower primer, CTCCGATTCCTCTTCAGTGC, 551C, 27 cycles (PCR fragment 172 bp).
Quantitative real-time PCR. To confirm independently some of the results from the semiquantitative RT-PCR experiments, qRT-PCR was conducted. The threshold line is set in the exponential phase of the amplification and the cycle at which the sample reaches this level is called the cycle threshold (C t ). Therefore, the lower the C t value is, the more the gene is expressed. As PCR products increase exponentially, a difference of one C t value equals a 2-fold difference. All genes were verified using the TaqMan Gene Expression Assays from Applied Biosystems (Foster City, CA) and reactions were performed as described. The reactions were carried out in triplicate per gene and cDNA. Averaged C t values of each qRT-PCR reaction from the target gene were standardized in relation to the averaged C t values of a housekeeping gene that ran in the same reaction plate. As for the semiquantitative RT-PCR experiments, TUBB (tubulin beta polypeptide, Assay ID Hs00742828_s1) was used to normalize expression levels. Expression of the genes KLF5 and Tr-gp96 in HT-29 cells was considered, as well as expression of KLF5 and TCFL5 in the siRNA knockdown experiments. Genes that were chosen for confirmation had the following assay IDs: TCFL5: Hs002324444_m1, Tr-gp96 (TRA1): Hs00427665_g1, KLF5: Hs00156145_m1. For each qRT-PCR reaction, the (averaged) C t value of the housekeeping gene was subtracted from the (averaged) C t value of the target gene, yielding the DC t value. The following formula was used to calculate the fold-change for a given gene between single and spheroid HT-29 cells from the DC t values: fold-change ¼ 2
ÀðDCt single cells À DCt spheroidsÞ .
Western blotting. Protein and total RNA from the same cells were isolated in parallel using the TRIzol reagent Sigma Kit as described in the instructions. Protein concentration was determined by the Biorad protein assay according to the method of Bradford. 43 A portion of protein (20 mg) per lane was separated in a 10% gel. ERBIN protein was detected by the enhanced chemiluminescence Western blotting method using a polyclonal anti-Erbin antibody (1:500) and a horseradish peroxidase-conjugated anti-rabbit secondary antibody (1:4,000) (SantaCruz-Biotechnologies) with the Pierce/Perbio detection kit. Protein loading was monitored by an anti-b-tubulin rabbit monoclonal IgG antibody (1:1,000).
Proliferation assay. Transfected and untransfected HT-29 cells were seeded in 12-well culture plates (5 Â 10 4 cells/well) and were cultured for 3 days in McCoy's 5A medium supplemented with 10% FBS, 2 mM glutamine (vol/vol). Then, cells were trypsinized and counted using the CASY-1 system based on the Coulter-counter principle (Schärfe, Reutlingen, Germany).
Statistics. Data are expressed as the arithmetic mean7SD. Statistical analysis was performed using the Mann-Whitney U-test. Po0.05 was considered statistically significant.
